Bluejay Diagnostics (BJDX) Total Liabilities (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Total Liabilities data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities changed 0.41% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (changed 0.41% YoY), and the FY2025 full-year result was $1.1 million, up 23.28% from the prior year.
• Total Liabilities rose to $1.4 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $3.0 million in Q3 2023 to a low of $927924.0 in Q4 2024.
• A 5-year average of $1.6 million and a median of $1.6 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 210.75% in 2022 and plunged 60.8% in 2024, its largest moves.
• Tracing BJDX's Total Liabilities over 5 years: stood at $2.0 million in 2022, then retreated by 0.32% to $2.0 million in 2023, then tumbled by 52.99% to $927924.0 in 2024, then gained by 23.28% to $1.1 million in 2025, then grew by 23.9% to $1.4 million in 2026.
• Business Quant data shows BJDX's Total Liabilities at $1.4 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.